Australia's most trusted
source of pharma news
Friday, 19 December 2025
Posted 17 December 2025 AM
Novartis has named former Roche Diagnostics Managing Director Allison Rossiter as its new Country President for Australia and New Zealand.
Rossiter, who left Roche in September last year to take the role of CEO at ASX-listed molecular diagnostics company Genetic Signatures, will kick off with Novartis in March.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.